Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket
ElectronicAdd to Basket
Site LicenseAdd to Basket

<< Back to Search Results



Erythropoietin State-of-the-Science and Strategic Opportunities
BioStrategy, Jan 2000, Pages: 25


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The market for recombinant human erythropoietin (rHuEpo) is very lucrative. It has been growing at an average annual growth rate of 20% over the previous 5 years. Market size currently stands at US$4.1 billion and profitability is very high.


1. Margins are large since prices reflect the benefits of the product rather than its actual production cost. 2. Marketing costs are low due to a very well defined captive patient population. 3. Distribution costs are low due to direct distribution strategies and the limited number of specialized centers that prescribe the product. 4. R-HuEpo is a repeat product targeted at a chronic patient population with annual cost of therapy exceeding $6,000 / patient. 5. Limited number of marketing companies reflect the fact that the market is a virtual oligopoly with limited competitive pressures.


Currently there are several windows of opportunities opening in the market for r-HuEpo and related products. Super generics, new molecules and novel technologies are just few of the many entry strategies available to companies wishing to participate in this important market.

Erythropoietin, State-of-the-Science and Strategic Opportunities is a strategic business report that assesses both the technology status and the competitive landscape of the r-HuEpo market. The report examines both the US and the European markets in detail, profiles leading products and companies and offer revenue forecasts to the year 2005. The report assesses the market attractiveness and potential and evaluates different options for market entry.




Customers who bought this item also bought

Nexe grupa d.d. - Strategic Analysis Review

INA - Industrija Nafte d.d. Zagreb - Strategic Analysis Review

Sava DD

Istrabenz DD

INA - Industrija Nafte d.d. Zagreb - Energy Oil and Gas - SWOT Report

Krka DD Novo Mesto

Gorenje Gospodinjski Aparati dd

Pivovarna Lasko DD

Telekom Slovenije DD

Luka Koper, d.d.

Dukat d.d. (formerly known as Lura d.d.) (Croatia) - Company Profile

JP BH Telecom d.d. (Bosnia and Herzegovina) - Company Profile



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds